- Home
- DSGX vs TECH Comparison
DSGX vs TECH Comparison
Compare DSGX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSGX | TECH |
|---|---|---|
| Founded | 1981 | 1976 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 9.2B |
| IPO Year | 1999 | 1989 |
Fundamental Metrics
Financial Performance| Metric | DSGX | TECH |
|---|---|---|
| Price | $85.69 | $65.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $117.11 | $70.46 |
| AVG Volume (30 Days) | 347.9K | ★ 1.6M |
| Earning Date | 12-03-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ 12.65 | N/A |
| EPS | ★ 1.78 | 0.49 |
| Revenue | $703,706,000.00 | ★ $1,216,732,000.00 |
| Revenue This Year | $12.36 | $2.33 |
| Revenue Next Year | $10.93 | $7.05 |
| P/E Ratio | ★ $48.05 | $134.12 |
| Revenue Growth | ★ 11.39 | 3.85 |
| 52 Week Low | $78.88 | $46.01 |
| 52 Week High | $124.31 | $79.28 |
Technical Indicators
Market Signals| Indicator | DSGX | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 68.64 |
| Support Level | $83.57 | $58.40 |
| Resistance Level | $88.22 | $66.48 |
| Average True Range (ATR) | 1.62 | 1.57 |
| MACD | -0.56 | 0.78 |
| Stochastic Oscillator | 30.66 | 86.10 |
Price Performance
Historical ComparisonAbout DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.